Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
Status:
RECRUITING
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether intensive chemotherapy combined with early, adequate, and intensive use of Rituximab for aggressive B-NHL in children and adolescents can improve the EFS and OS compared with the historical study CCCG-BNHL-2015.
Phase:
PHASE2
Details
Lead Sponsor:
Children's Cancer Group, China
Collaborators:
Children's Hospital of Soochow University Nanjing Children's Hospital Qilu Hospital of Shandong University Shanghai Children's Medical Center Tianjin Medical University Cancer Institute and Hospital West China Second University Hospital Wuhan TongJi Hospital Xiangya Hospital of Central South University